Olivia A. Vogel

Dr. Olivia A. Vogel

Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
OVOlivia A. Vogel
Olivia A. Vogel
JHJulianna Han
Julianna Han
CLChieh-Yu Liang
Chieh-Yu Liang
SMSanthakumar Manicassamy
Santhakumar Manicassamy
JPJasmine T. Perez
Jasmine T. Perez
Balaji ManicassamyBalaji Manicassamy
Balaji Manicassamy
Signaling through retinoic acid inducible gene I (RIG-I) like receptors (RLRs) is tightly regulated, with activation occurring upon sensing of viral nucleic acids, and suppression mediated by negative regulators. Under homeostatic conditions aberrant activation of melanoma differentiation-associated protein-5 (MDA5) is prevented through editing of endogenous dsRNA by RNA editing enzyme Adenosine Deaminase Acting on RNA (ADAR1). In addition, ADAR1 is postulated to play pro-viral and antiviral roles during viral infections that are dependent or independent of RNA editing activity. Here, we investigated the importance of ADAR1 isoforms in modulating influenza A virus (IAV) replication and revealed the opposing roles for ADAR1 isoforms, with the nuclear p110 isoform restricting versus the cytoplasmic p150 isoform promoting IAV replication. Importantly, we demonstrate that p150 is critical for preventing sustained RIG-I signaling, as p150 deficient cells showed increased IFN-β expression and apoptosis during IAV infection, independent of RNA editing activity. Taken together, the p150 isoform of ADAR1 is important for preventing sustained RIG-I induced IFN-β expression and apoptosis during viral infection. Viruses as intracellular pathogens need to precisely block or usurp certain host proteins to create a hospitable environment for viral replication. In this study, we investigated the significance of host protein ADAR1 and different isoforms of ADAR1 in influenza virus replication. Through gene deletion of specific ADAR1 isoforms, our study reveals opposing roles for the two isoforms of ADAR1. Influenza virus replication was increased in cells lacking the p110 isoform of ADAR1, indicating that p110 hinders influenza virus replication. In contrast, cells lacking the p150 isoform of ADAR1 showed decreased influenza virus replication, indicating that p150 promotes influenza virus replication. In response to viral infection, host cells mount antiviral defenses to contain viral spread and these antiviral defenses when left unchecked can cause excessive inflammation and tissue damage. As such, antiviral defense pathways are tightly controlled by positive and negative regulators to prevent aberrant activation or to shut-down inflammatory responses in a timely manner. In this study, we have identified that p150 deficient cells exhibit uncontrolled activation of antiviral pathways and increased cell death during influenza virus infection, creating an inhospitable environment in the cell for viral replication. In summary, our studies reveal that the p150 isoform of ADAR1 promotes influenza virus replication by regulating cellular antiviral defense pathways.

10 May 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JHJulianna Han
Julianna Han
Ketaki GantiKetaki Ganti
Ketaki Ganti
VSVeeresh Kumar Sali
Veeresh Kumar Sali
CTCarly Ann Irene Twigg
Carly Ann Irene Twigg
YZYifeng Zhang
Yifeng Zhang
Balaji ManicassamyBalaji Manicassamy
Balaji Manicassamy
It is well documented that influenza A viruses selectively package 8 distinct viral ribonucleoprotein complexes (vRNPs) into each virion; however, the role of host factors in genome assembly is not completely understood. To evaluate the significance of cellular factors in genome assembly, we generated a reporter virus carrying a tetracysteine tag in the NP gene (NP-Tc virus) and assessed the dynamics of vRNP localization with cellular components by fluorescence microscopy. At early time points, vRNP complexes were preferentially exported to the MTOC; subsequently, vRNPs associated on vesicles positive for cellular factor Rab11a and formed distinct vRNP bundles that trafficked to the plasma membrane on microtubule networks. In Rab11a deficient cells, however, vRNP bundles were smaller in the cytoplasm with less co-localization between different vRNP segments. Furthermore, Rab11a deficiency increased the production of non-infectious particles with higher RNA copy number to PFU ratios, indicative of defects in specific genome assembly. These results indicate that Rab11a+ vesicles serve as hubs for the congregation of vRNP complexes and enable specific genome assembly through vRNP:vRNP interactions, revealing the importance of Rab11a as a critical host factor for influenza A virus genome assembly.

29 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
OVOlivia A. Vogel
Olivia A. Vogel
JFJade Kenneth Forwood
Jade Kenneth Forwood
DLDaisy Leung
Daisy Leung
GAGaya Amarasinghe
Gaya Amarasinghe
CBChristopher F Basler
Christopher F Basler
Cellular nucleocytoplasmic trafficking is mediated by the importin family of nuclear transport proteins. The well-characterized importin alpha (IMPA) and importin beta (IMPB) nuclear import pathway plays a crucial role in the innate immune response to viral infection by mediating the nuclear import of transcription factors such as IRF3, NFκB, and STAT1. The nuclear transport of these transcription factors ultimately leads to the upregulation of a wide range of antiviral genes, including IFN and IFN-stimulated genes (ISGs). To replicate efficiently in cells, viruses have developed mechanisms to block these signaling pathways. One strategy to evade host innate immune responses involves blocking the nuclear import of host antiviral transcription factors. By binding IMPA proteins, these viral proteins prevent the nuclear transport of key transcription factors and suppress the induction of antiviral gene expression. In this review, we describe examples of proteins encoded by viruses from several different families that utilize such a competitive inhibition strategy to suppress the induction of antiviral gene expression.

31 May 2023 in Viruses
Verified
Journal Article
Open access
PDF file
CDCamilla Maree Donnelly
Camilla Maree Donnelly
OVOlivia A. Vogel
Olivia A. Vogel
MEMegan R. Edwards
Megan R. Edwards
PTPaige E. Taylor
Paige E. Taylor
JRJustin Roby
Justin Roby
CBChristopher F Basler
Christopher F Basler
Nipah virus (NiV) and Hendra virus (HeV) are highly pathogenic species from the Henipavirus genus within the paramyxovirus family and are harbored by Pteropus Flying Fox species. Henipaviruses cause severe respiratory disease, neural symptoms, and encephalitis in various animals and humans, with human mortality rates exceeding 70% in some NiV outbreaks. The henipavirus matrix protein (M), which drives viral assembly and budding of the virion, also performs non-structural functions as a type I interferon antagonist. Interestingly, M also undergoes nuclear trafficking that mediates critical monoubiquitination for downstream cell sorting, membrane association, and budding processes. Based on the NiV and HeV M X-ray crystal structures and cell-based assays, M possesses a putative monopartite nuclear localization signal (NLS) (residues 82KRKKIR87; NLS1 HeV), positioned on an exposed flexible loop and typical of how many NLSs bind importin alpha (IMPα), and a putative bipartite NLS (244RR-10X-KRK258; NLS2 HeV), positioned within an α-helix that is far less typical. Here, we employed X-ray crystallography to determine the binding interface of these M NLSs and IMPα. The interaction of both NLS peptides with IMPα was established, with NLS1 binding the IMPα major binding site, and NLS2 binding as a non-classical NLS to the minor site. Co-immunoprecipitation (co-IP) and immunofluorescence assays (IFA) confirm the critical role of NLS2, and specifically K258. Additionally, localization studies demonstrated a supportive role for NLS1 in M nuclear localization. These studies provide additional insight into the critical mechanisms of M nucleocytoplasmic transport, the study of which can provide a greater understanding of viral pathogenesis and uncover a potential target for novel therapeutics for henipaviral diseases.

28 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
PRPalaniappan Ramanathan
Palaniappan Ramanathan
BTBersabeh Tigabu
Bersabeh Tigabu
RSRodrigo Santos
Rodrigo Santos
Philipp IlinykhPhilipp Ilinykh
Philipp Ilinykh
NKNATALIA KUZMINA
NATALIA KUZMINA
Alexander BukreyevAlexander Bukreyev
Alexander Bukreyev
Members of the Ebolavirus genus demonstrate a marked differences in pathogenicity in humans with Ebola (EBOV) being the most pathogenic, Bundibugyo (BDBV) less pathogenic, and Reston (RESTV) is not known to cause a disease in humans. The VP24 protein encoded by members of the Ebolavirus genus blocks type I interferon (IFN-I) signaling through interaction with host karyopherin alpha nuclear transporters, potentially contributing to virulence. Previously, we demonstrated that BDBV VP24 (bVP24) binds with lower affinities to karyopherin alpha proteins relative to EBOV VP24 (eVP24), and this correlated with a reduced inhibition in IFN-I signaling. We hypothesized that modification of eVP24-karyopherin alpha interface to make it similar to bVP24 would attenuate the ability to antagonize IFN-I response. We generated a panel of recombinant EBOVs containing single or combinations of point mutations in the eVP24-karyopherin alpha interface. Most of the viruses appeared to be attenuated in both IFN-I-competent 769-P and IFN-I-deficient Vero-E6 cells in the presence of IFNs. However, the R140A mutant grew at reduced levels even in the absence of IFNs in both cell lines, as well as in U3A STAT1 knockout cells. Both the R140A mutation and its combination with the N135A mutation greatly reduced the amounts of viral genomic RNA and mRNA suggesting that these mutations attenuate the virus in an IFN-I-independent attenuation. Additionally, we found that unlike eVP24, bVP24 does not inhibit interferon lambda 1 (IFN-λ1), interferon beta (IFN-β), and ISG15, which potentially explains the lower pathogenicity of BDBV relative to EBOV. Thus, the VP24 residues binding karyopherin alpha attenuates the virus by IFN-I-dependent and independent mechanisms.

6 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
JHJulianna Han
Julianna Han
Ketaki GantiKetaki Ganti
Ketaki Ganti
VSVeeresh Kumar Sali
Veeresh Kumar Sali
CTCarly Twigg
Carly Twigg
YZYifeng Zhang
Yifeng Zhang
Balaji ManicassamyBalaji Manicassamy
Balaji Manicassamy
Summary: It is well documented that influenza A viruses selectively package 8 distinct viral ribonucleoprotein complexes (vRNPs) into each virion; however, the role of host factors in genome assembly is not completely understood. To evaluate the significance of cellular factors in genome assembly, we generated a reporter virus carrying a tetracysteine tag in the NP gene (NP-Tc virus) and assessed the dynamics of vRNP localization with cellular components by fluorescence microscopy. At early time points, vRNP complexes were preferentially exported to the MTOC; subsequently, vRNPs associated on vesicles positive for cellular factor Rab11a and formed distinct vRNP bundles that trafficked to the plasma membrane on microtubule networks. In Rab11a deficient cells, however, vRNP bundles were smaller in the cytoplasm with less co-localization between different vRNP segments. Furthermore, Rab11a deficiency increased the production of non-infectious particles with higher RNA copy number to PFU ratios, indicative of defects in specific genome assembly. These results indicate that Rab11a+ vesicles serve as hubs for the congregation of vRNP complexes and enable specific genome assembly through vRNP:vRNP interactions, revealing the importance of Rab11a as a critical host factor for influenza A virus genome assembly.